Original Research
Accepted on 04 Apr 2025
Immune Architecture in Stage III and IV Melanoma Identifies Distinct Patient Subgroups
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1560778
Type at least 3 characters
43,061 articles
Correction
Accepted on 04 Apr 2025
Corrigendum: Extracellular vesicles from human breast cancerresistant cells promote acquired drug resistance and proinflammatory macrophage response
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1595885
Review
Accepted on 04 Apr 2025
The mechanism of action and therapeutic potential of tumor-associated macrophages in tumor immune evasion
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1545928
Original Research
Accepted on 04 Apr 2025
Clinical Manifestations and Risk Factors of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1 Inhibitors: A Case-Control Study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1581057
Original Research
Accepted on 04 Apr 2025
Quantifying treatment response to a macrophage-targeted therapy in combination with immune checkpoint inhibitors after exposure to conventional chemotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1565953
Original Research
Accepted on 04 Apr 2025
A predictive model for the transformation from cervical inflammation to cancer based on tumor immune-related factors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1532048
Original Research
Accepted on 04 Apr 2025
Mimicking Immune Complexes for efficient Antibody Responses
in B Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1570487
Original Research
Accepted on 04 Apr 2025
Genome-wide association study and transcriptomic analysis reveal the crucial role of sting1 in resistance to visceral white-nodules disease in Larimichthys polyactis
in Comparative Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1562307
Correction
Accepted on 04 Apr 2025
Corrigendum: Case Report: HLA-DRB1 04:01 found in a child with adenovirus type 2 -linked hepatitis
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1592744
Review
Accepted on 04 Apr 2025
Monoamine Signaling and Neuroinflammation: Mechanistic Connections and Implications for Neuropsychiatric Disorders
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1543730
Opinion
Accepted on 04 Apr 2025
Value of Animal Sepsis Research in Navigating the Translational Labyrinth
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1593342
Original Research
Accepted on 04 Apr 2025
FOXA2/miR-148a-3p/SMURF2 signaling feed-forward loop alleviates spinal cord ischemia-reperfusion injury-induced neuropathic pain by modulating microglia polarization in rats
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1563377
Original Research
Accepted on 04 Apr 2025
Mapping the genetic landscape of immune-mediated disorders: potential implications for classification and therapeutic strategies
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1543781
Original Research
Accepted on 04 Apr 2025
To Determine the Role of TRIT1 in the Diagnosis, Prognosis and Immunoinvasion of Liver Hepatocellular Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1563442
Original Research
Accepted on 04 Apr 2025
Different pathways responses involving Tfh cells delay parasite-specific antibody production in Trypanosoma cruzi acute experimental models
in Parasite Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1487317
Case Report
Published on 04 Apr 2025
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1563736
- 218 views